We decided to concentrate on one of the genes in the canonical Wnt signaling pathway, B cell lymphoma-9 (BCL9), because it was found to serve as a co-factor of β-catenin in early 2000 [35], however, there were no previous studies on the role of BCL9 in breast cancer. The gene discussed is BCL9; the disease is breast carcinoma.